The SPDR S&P Biotech ETF (XBI) provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. For XBI Options Trading, they trade with only Friday expirations priced in increments of $0.50. and are a very popular, low priced play which can often provide weekly gains of over 5,000%.
2016 – 2018 Ranges: (44.16 – 69.21) (58.66 – 88.98) (64.38 – 101.55)
1-Month Range: 83.33 – 88.91
Weekly Chart
Daily Chart
5 Day Chart
Pivot Points
(updated weekly after Friday’s close)
| Support/Resistance Levels | Price | Key Turning Points |
|---|---|---|
| 14 Day RSI at 80% | 107.65 | |
| 52-Week High | 100.70 | |
| 14 Day RSI at 70% | 95.02 | |
| 13-Week High | 89.30 | |
| 1-Month High | 88.07 | |
| Pivot Point 2nd Level Resistance | 85.99 | |
| High | 85.05 | High |
| Pivot Point 1st Resistance Point | 85.01 | |
| 84.91 | 14 Day RSI at 50% | |
| Previous Close | 84.80 | Previous Close |
| 84.07 | Pivot Point | |
| Last | 84.03 | Last |
| Low | 83.13 | Low |
| Pivot Point 1st Support Point | 83.09 | |
| Pivot Point 2nd Support Point | 82.15 | |
| 1-Month Low | 80.45 | |
| 13-Week Low | 79.31 | |
| 14 Day RSI at 30% | 75.97 | |
| 14 Day RSI at 20% | 64.80 | |
| 52-Week Low | 64.38 |
